Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Net Margin (2016 - 2025)

Medifast (MED) has disclosed Net Margin for 16 consecutive years, with 24.13% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 2480.0% year-over-year to 24.13%, compared with a TTM value of 4.84% through Dec 2025, down 519.0%, and an annual FY2025 reading of 4.84%, down 519.0% over the prior year.
  • Net Margin was 24.13% for Q4 2025 at Medifast, down from 2.52% in the prior quarter.
  • Across five years, Net Margin topped out at 12.05% in Q1 2021 and bottomed at 24.13% in Q4 2025.
  • Average Net Margin over 5 years is 4.5%, with a median of 8.25% recorded in 2022.
  • Peak annual rise in Net Margin hit 718bps in 2025, while the deepest fall reached -2480bps in 2025.
  • Year by year, Net Margin stood at 9.0% in 2021, then dropped by -13bps to 7.86% in 2022, then crashed by -60bps to 3.16% in 2023, then crashed by -79bps to 0.67% in 2024, then tumbled by -3707bps to 24.13% in 2025.
  • Business Quant data shows Net Margin for MED at 24.13% in Q4 2025, 2.52% in Q3 2025, and 2.34% in Q2 2025.